Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months
In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles
Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions
DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal
DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway
Trending Stories
- Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts - Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing
- Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost
- Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”